Mattingly: There’s no silver lining or bright spots for many people over the last several months. Do you feel that whenever we get back to normal, this will end up almost being beneficial for the reach you were able to achieve?
New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients
WASHINGTON, Oct. 8, 2020
WASHINGTON, Oct. 8, 2020 /PRNewswire/ — Today, the Berkeley Research Group (BRG) published an analysis of historical trends in 340B contract pharmacy arrangements. The findings conclude that the growth in the number of these arrangements is fueling explosive growth in the program at large and driving the 340B program farther and farther away from its original intended goal of providing discounted medicines to safety-net entities treating uninsured and vulnerable patients.
Congress created the 340B program to help safety-net providers, including certain qualifying hospitals and federally-funded clinics, access discounts on prescription medicines for low-income or uninsured patients. In 2010, a Health Resources and Services Administration (HRSA) policy opened the door to allow